Abstract
Early-onset acute myocardial infarction (AMI) may have a higher genetic predisposition than late-onset AMI does. The present study aimed to identify and characterize germline variants that affect early-onset AMI using whole-genome sequencing (WGS). We performed a genome-wide association study based on WGS of 1,239 Koreans, including 596 early-onset AMI patients and 643 healthy individuals. Patients with AMI who underwent percutaneous coronary intervention (PCI) caused by atherothrombotic occlusive lesions were included in the study. A total of 29 novel loci were found to be associated with early-onset AMI. These loci are involved in thrombosis, fibrinolysis, inflammation, and lipid metabolism. One of the associated single nucleotide variants (SNVs), rs1614576, located upstream of PRKCB, is known to be associated with thrombus formation. Additionally, the results revealed a novel locus, rs78631167, located upstream of PLAUR which plays a critical role in regulating plasminogen activation and is related to fibrinolysis. The association between early-onset AMI and rs9357455, which is located upstream of PHACTR1 that regulates inflammation in AMI, was found. Moreover, we could identify a lipid metabolism related genetic risk locus, rs5072, in the APOA1-AS gene. This study provides new evidence supporting the genetic association between early-onset AMI and thrombosis and fibrinolysis, as well as inflammation and lipid metabolism, by analyzing the whole-genome of 596 patients with early-onset AMI who have been treated with PCI. Our findings highlight potential genetic markers for the prediction and management of AMI, as well as for understanding the etiology of AMI.
Competing Interest Statement
SJ, BK, YK, and YJK were employed by Clinomics Inc. BCK and JB are the CEOs of Clinomics Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.
Funding Statement
This work was supported by the Promotion of Innovative Businesses for Regulation-Free Special Zones funded by the Ministry of SMEs and Startups (MSS, Korea) [grant number P0016195, P0016193 (1425156792, 1425157301) (2.220035.01, 2.220036.01)]. This work was also supported by the Establishment of Demonstration Infrastructure for Regulation-Free Special Zones fund (MSS, Korea) [grant number P0016191 (2.220037.01) (1425157253)] by the Ministry of SMEs and Startups.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Ulsan National Institute of Science and Technology (UNISTIRB-15-19-A) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Full summary statistics relating to the GWAS analysis and other relevant data are available upon request to the authors.
ABBREVIATIONS
- AMI
- acute myocardial infarction
- PCI
- percutaneous coronary intervention
- GWAS
- genome-wide association study
- WGS
- whole-genome sequencing
- SNV
- single nucleotide variant
- KGP
- Korean Genome Project
- STEMI
- ST-segment elevation myocardial infarction
- NSTEMI
- non-ST-segment elevation myocardial infarction
- QTL
- quantitative trait loci
- eQTL
- expression QTL
- sQTL
- splicing QTL
- mQTL
- methylation QTL
- PRKCB
- protein kinase C beta
- PLAUR
- plasminogen activator, urokinase receptor
- PAFAH1B2
- platelet-activating factor acetylhydrolase 1b catalytic subunit 2
- PHACTR1
- phosphatase and actin regulator 1
- APOA1-AS
- apolipoprotein A1 antisense RNA
- PPI
- protein-protein interaction
